
Management of panurothelial disease in superficial bladder cancer
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

ABSTRACT BACKGROUND A 59-year-old female presented with a history of recurrent superficial bladder cancer. Since the initial diagnosis 12 years earlier, she had had 12 recurrences, all
treated with transurethral resection with adjuvant bacillus Calmette–Guérin and mitomycin C. Pathology samples had always shown Ta grade 1 transitional-cell carcinoma. At the last
recurrence, she presented with several papillary lesions throughout the bladder, discovered on control cystoscopy. Transurethral resection revealed a papillary grade 3 transitional-cell
carcinoma of the bladder. INVESTIGATIONS Intravenous urography and ureteroscopy. DIAGNOSIS Panurothelial superficial transitional-cell carcinoma. MANAGEMENT Radical cystectomy with total
right ureterectomy and distal left ureterectomy. Reconstruction of the urinary tract was performed with the distal ileum detubulized and rearranged in a U shape. A pyeloileal anastomosis and
a proximal ureteroileal anastomosis were performed at the right and left sides respectively. Access through your institution Buy or subscribe This is a preview of subscription content,
access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn
more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS
OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Jemal A _ et al_. (2005) Cancer statistics, 2005. _CA Cancer J Clin_ 55:
10–30 Article Google Scholar * Fujii Y _ et al_. (2003) Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. _BJU Int_ 92: 559–562 Article CAS Google
Scholar * Solsona E _ et al_. (2002) Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications. _J Urol_ 167: 2007–2011 Article CAS Google
Scholar * Mullerad M _ et al_. (2004) Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. _J Urol_ 172: 2177–2181 Article Google Scholar * Herr HW _ et al_.
(1992) Bacillus Calmette–Guerin therapy for superficial bladder cancer: a 10-year followup. _J Urol_ 147: 1020–1023 Article CAS Google Scholar * Herr HW (2005) Restaging transurethral
resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette–Guerin therapy. _J Urol_ 174: 2134–2137 Article Google Scholar * Martinez-Pineiro JA _
et al_. (2005) Has a 3-fold decreased dose of bacillus Calmette–Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of
a prospective randomized trial. _J Urol_ 174: 1242–1247 Article Google Scholar * Sylvester RJ _ et al_. (2004) A single immediate postoperative instillation of chemotherapy decreases the
risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. _J Urol_ 171: 2186–2190 Article Google Scholar *
Oosterlinck W (2004) Guidelines on diagnosis and treatment of superficial bladder cancer. _Minerva Urol Nefrol_ 56: 65–72 CAS PubMed Google Scholar * Smith JA Jr _ et al_. (1999) Bladder
cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. _J Urol_ 162: 1697–1701
Article Google Scholar * Herr HW and Sogani PC (2001) Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? _J Urol_ 166: 1296–1299 Article CAS
Google Scholar * Nesrallah LJ _ et al_. (2005) Experience with the orthotopic ileal neobladder in women: a mid-term follow-up. _BJU Int_ 95: 1045–1047 Article Google Scholar Download
references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Professor of Urology in the Department of Surgery and Chairman of the Division of Urology at the Hospital das Clínicas at the
University of São Paulo Medical School, Miguel Srougi * Assistant Professors in the Division of Urology and staff members of the Hospital das Clínicas at the University of São Paulo Medical
School in São Paulo, Rua Barata Ribeiro, 414, 7° andar, Bela Vista, São Paulo, 01308–000, SP, Brazil Alberto A Antunes, Marcos F Dall'Oglio & José Cury Authors * Miguel Srougi View
author publications You can also search for this author inPubMed Google Scholar * Alberto A Antunes View author publications You can also search for this author inPubMed Google Scholar *
Marcos F Dall'Oglio View author publications You can also search for this author inPubMed Google Scholar * José Cury View author publications You can also search for this author
inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Miguel Srougi. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing financial interests. RIGHTS AND
PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Srougi, M., Antunes, A., Dall'Oglio, M. _et al._ Management of panurothelial disease in superficial bladder
cancer. _Nat Rev Urol_ 3, 284–288 (2006). https://doi.org/10.1038/ncpuro0489 Download citation * Received: 12 December 2005 * Accepted: 27 March 2006 * Issue Date: 01 May 2006 * DOI:
https://doi.org/10.1038/ncpuro0489 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently
available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative